
Shanghai Conant Optical Co., Ltd.
2276.HKHKSEHealthcareMedical - Instruments & Supplies
Latest quote
HK$41.10
+HK$1.14 · +2.85%
2276.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company websiteShanghai Conant Optical Co., Ltd. specializes in the global production and sale of resin eyeglass lenses. The company's extensive reach covers continents such as Asia, Europe, North and South America, Africa, and Oceania, in addition to its home market of China. It supplies a diverse range of optical solutions, including both standardized products and custom-tailored lenses. Its primary clientele consists of brand owners within the spectacle lens industry and various ophthalmic optics enterprises. The firm was established in 2011 and operates from its headquarters in Shanghai, China.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- Headquarters
- CN
- CEO
- Zhengxiang Fei
- Listed since
- Dec 16, 2021
- Employees
- 3,231
Market position
Day range
Current HK$41.10
52-week range
Current HK$41.10
- Open
- HK$39.96
- Previous close
- HK$39.96
- Volume
- 824.3K
- 0.33× average
- Average volume
- 2.48M
- Average daily volume
- Market cap
- 19.87B HKD
- Beta
- 0.31
- Market reference 1
- 50-day average
- HK$34.1452
- +20.37% above average
- 200-day average
- HK$47.8245
- -14.06% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 22.16B CNY
- P/E (TTM)
- 28.88×
- P/B (TTM)
- 4.42×
- P/S (TTM)
- 7.56×
- EV / EBITDA
- 32.48×
- Earnings yield
- 2.47%
- Free cash flow yield
- 1.07%
- Dividend yield
- 0.96%
Profitability & efficiency
- Gross margin
- 42.91%
- Operating margin
- 30.75%
- Net margin
- 25.83%
- Return on equity
- 20.32%
- Return on assets
- 15.73%
- Return on invested capital
- 16.99%
Financial health
- Debt / equity
- 0.17×
- Current ratio
- 3.59×
- Altman Z-score
- 10.19
- Piotroski F-score
- 5 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.19B CNY | 2.06B CNY | 1.76B CNY | 1.56B CNY | 1.36B CNY |
| Cost of goods sold | 1.27B CNY | 1.27B CNY | 1.1B CNY | 1.02B CNY | 895.92M CNY |
| Gross profit | 917.46M CNY | 795.1M CNY | 658.13M CNY | 537.87M CNY | 460.16M CNY |
| Research and development | 97.44M CNY | 95.78M CNY | 77.45M CNY | 65.83M CNY | 47.51M CNY |
| Selling, general, and administrative | 217.34M CNY | 323.78M CNY | 278.17M CNY | 224.71M CNY | 222.01M CNY |
| Operating expenses | 314.78M CNY | 307.2M CNY | 271.82M CNY | 297.83M CNY | 214.87M CNY |
| Interest income | 13.4M CNY | 5.87M CNY | 3.57M CNY | 2.43M CNY | 275K CNY |
| Interest expense | 6.01M CNY | 10.23M CNY | 13.65M CNY | 25.74M CNY | 34.95M CNY |
| Depreciation and amortization | 79.97M CNY | 74.44M CNY | 59.11M CNY | 47.69M CNY | 46.83M CNY |
| Operating income | 602.68M CNY | 487.9M CNY | 386.32M CNY | 240.04M CNY | 208.81M CNY |
| Net income | 557.72M CNY | 428.28M CNY | 327.02M CNY | 248.57M CNY | 183.52M CNY |
Company facts updated Aug 24, 2026.
Earnings
- Latest EPS result
- 0.73
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
2276.HK peers
ETFs holding 2276.HK
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core MSCI Emerging Markets ETFIEMG11.7M0.01%160B USD0.09%$81.57+0.64%
Vanguard Total International Stock ETFVXUS11.64M0.00%646.2B USD0.05%$87.71+0.78%
Vanguard FTSE Emerging Markets ETFVWO11.02M0.01%162.3B USD0.06%$60.45+0.72%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS3.22M0.02%13.6B USD0.06%$160.06+0.43%
WisdomTree Emerging Markets SmallCap Dividend FundDGS2.03M0.11%1.74B USD0.58%$63.34+0.17%
abrdn International Small Cap Active ETFASCI981.59K1.22%80.24M USD1.05%$36.738+0.49%
VictoryShares Emerging Markets Value Momentum ETFUEVM925.72K0.37%253.46M USD0.53%$60.346+1.03%
iShares Core MSCI Total International Stock ETFIXUS913.62K0.00%60.91B USD0.07%$97.945+0.76%
iShares Core MSCI Emerging Markets ETFIEMG- Market value
- 11.7M
- Weight
- 0.01%
- AUM
- 160B USD
- Expense ratio
- 0.09%
- Price / 1D
- $81.57+0.64%
Vanguard Total International Stock ETFVXUS- Market value
- 11.64M
- Weight
- 0.00%
- AUM
- 646.2B USD
- Expense ratio
- 0.05%
- Price / 1D
- $87.71+0.78%
Vanguard FTSE Emerging Markets ETFVWO- Market value
- 11.02M
- Weight
- 0.01%
- AUM
- 162.3B USD
- Expense ratio
- 0.06%
- Price / 1D
- $60.45+0.72%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS- Market value
- 3.22M
- Weight
- 0.02%
- AUM
- 13.6B USD
- Expense ratio
- 0.06%
- Price / 1D
- $160.06+0.43%
WisdomTree Emerging Markets SmallCap Dividend FundDGS- Market value
- 2.03M
- Weight
- 0.11%
- AUM
- 1.74B USD
- Expense ratio
- 0.58%
- Price / 1D
- $63.34+0.17%
abrdn International Small Cap Active ETFASCI- Market value
- 981.59K
- Weight
- 1.22%
- AUM
- 80.24M USD
- Expense ratio
- 1.05%
- Price / 1D
- $36.738+0.49%
VictoryShares Emerging Markets Value Momentum ETFUEVM- Market value
- 925.72K
- Weight
- 0.37%
- AUM
- 253.46M USD
- Expense ratio
- 0.53%
- Price / 1D
- $60.346+1.03%
iShares Core MSCI Total International Stock ETFIXUS- Market value
- 913.62K
- Weight
- 0.00%
- AUM
- 60.91B USD
- Expense ratio
- 0.07%
- Price / 1D
- $97.945+0.76%
Continue in GoAI
Research 2276.HKresearch.disclaimer





